USP15 can deubiquitinate PARKIN to impair mitochondrial autophagy, suggesting that USP15 inhibition could be a therapeutic strategy for Parkinson’s disease, caused by reduced PARKIN levels [96,97]. The gene discussed is PRKN; the disease is Parkinson disease.